Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features

Chao Wen Cheng, Jen Liang Su, Chiao Wen Lin, Chun Wen Su, Chun Han Shih, Shun Fa Yang, Ming Hsien Chien

研究成果: 雜誌貢獻文章

33 引文 (Scopus)

摘要

Background: Constitutive activation of nuclear factor (NF)-κB is frequently observed in hepatocellular carcinoma (HCC). The current study examined associations of polymorphisms within promoter regions of NFKB1 encoding NF-κB1 and NFKBIA encoding IκBα with the susceptibility of developing HCC and clinicopathological characteristics of the tumors. Methodology and Principal Findings: Genetic polymorphisms of NFKB1 and NFKBIA were analyzed by a real-time polymerase chain reaction (PCR) in 135 HCC patients and 520 healthy controls. The genotypic frequency of the NFKB1 -94 Ins polymorphism in HCC patients was significantly higher than that of the controls (adjusted odds ratio (AOR) = 2.23; 95% confidence interval (CI) 1.32~3.77). No statistical significance was observed for the distribution frequency of the NFKBIA --519 C/T, -826 C/T, or -881 A/G genotype and haplotype polymorphisms between HCC patients and controls. Furthermore, female HCC patients carrying the NFKB1 -94 Ins polymorphism were associated with lower clinical stages and smaller tumor sizes. Conclusions: Our results indicate that the NFKB1 -94 Ins promoter polymorphism increased the risk of HCC, and may be applied as a predictive factor for the clinical stage and tumor size in female HCC patients.

原文英語
文章編號e56130
期刊PLoS One
8
發行號2
DOIs
出版狀態已發佈 - 二月 14 2013

指紋

hepatoma
Polymorphism
Hepatocellular Carcinoma
Genes
genetic polymorphism
Tumors
genes
neoplasms
Polymerase chain reaction
promoter regions
Genetic Promoter Regions
Neoplasms
Genetic Polymorphisms
Chemical activation
odds ratio
Haplotypes
Real-Time Polymerase Chain Reaction
confidence interval
haplotypes
quantitative polymerase chain reaction

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

引用此文

Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features. / Cheng, Chao Wen; Su, Jen Liang; Lin, Chiao Wen; Su, Chun Wen; Shih, Chun Han; Yang, Shun Fa; Chien, Ming Hsien.

於: PLoS One, 卷 8, 編號 2, e56130, 14.02.2013.

研究成果: 雜誌貢獻文章

Cheng, Chao Wen ; Su, Jen Liang ; Lin, Chiao Wen ; Su, Chun Wen ; Shih, Chun Han ; Yang, Shun Fa ; Chien, Ming Hsien. / Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features. 於: PLoS One. 2013 ; 卷 8, 編號 2.
@article{722da4ccd84340628ecbb240cc8ced12,
title = "Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features",
abstract = "Background: Constitutive activation of nuclear factor (NF)-κB is frequently observed in hepatocellular carcinoma (HCC). The current study examined associations of polymorphisms within promoter regions of NFKB1 encoding NF-κB1 and NFKBIA encoding IκBα with the susceptibility of developing HCC and clinicopathological characteristics of the tumors. Methodology and Principal Findings: Genetic polymorphisms of NFKB1 and NFKBIA were analyzed by a real-time polymerase chain reaction (PCR) in 135 HCC patients and 520 healthy controls. The genotypic frequency of the NFKB1 -94 Ins polymorphism in HCC patients was significantly higher than that of the controls (adjusted odds ratio (AOR) = 2.23; 95{\%} confidence interval (CI) 1.32~3.77). No statistical significance was observed for the distribution frequency of the NFKBIA --519 C/T, -826 C/T, or -881 A/G genotype and haplotype polymorphisms between HCC patients and controls. Furthermore, female HCC patients carrying the NFKB1 -94 Ins polymorphism were associated with lower clinical stages and smaller tumor sizes. Conclusions: Our results indicate that the NFKB1 -94 Ins promoter polymorphism increased the risk of HCC, and may be applied as a predictive factor for the clinical stage and tumor size in female HCC patients.",
author = "Cheng, {Chao Wen} and Su, {Jen Liang} and Lin, {Chiao Wen} and Su, {Chun Wen} and Shih, {Chun Han} and Yang, {Shun Fa} and Chien, {Ming Hsien}",
year = "2013",
month = "2",
day = "14",
doi = "10.1371/journal.pone.0056130",
language = "English",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "2",

}

TY - JOUR

T1 - Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features

AU - Cheng, Chao Wen

AU - Su, Jen Liang

AU - Lin, Chiao Wen

AU - Su, Chun Wen

AU - Shih, Chun Han

AU - Yang, Shun Fa

AU - Chien, Ming Hsien

PY - 2013/2/14

Y1 - 2013/2/14

N2 - Background: Constitutive activation of nuclear factor (NF)-κB is frequently observed in hepatocellular carcinoma (HCC). The current study examined associations of polymorphisms within promoter regions of NFKB1 encoding NF-κB1 and NFKBIA encoding IκBα with the susceptibility of developing HCC and clinicopathological characteristics of the tumors. Methodology and Principal Findings: Genetic polymorphisms of NFKB1 and NFKBIA were analyzed by a real-time polymerase chain reaction (PCR) in 135 HCC patients and 520 healthy controls. The genotypic frequency of the NFKB1 -94 Ins polymorphism in HCC patients was significantly higher than that of the controls (adjusted odds ratio (AOR) = 2.23; 95% confidence interval (CI) 1.32~3.77). No statistical significance was observed for the distribution frequency of the NFKBIA --519 C/T, -826 C/T, or -881 A/G genotype and haplotype polymorphisms between HCC patients and controls. Furthermore, female HCC patients carrying the NFKB1 -94 Ins polymorphism were associated with lower clinical stages and smaller tumor sizes. Conclusions: Our results indicate that the NFKB1 -94 Ins promoter polymorphism increased the risk of HCC, and may be applied as a predictive factor for the clinical stage and tumor size in female HCC patients.

AB - Background: Constitutive activation of nuclear factor (NF)-κB is frequently observed in hepatocellular carcinoma (HCC). The current study examined associations of polymorphisms within promoter regions of NFKB1 encoding NF-κB1 and NFKBIA encoding IκBα with the susceptibility of developing HCC and clinicopathological characteristics of the tumors. Methodology and Principal Findings: Genetic polymorphisms of NFKB1 and NFKBIA were analyzed by a real-time polymerase chain reaction (PCR) in 135 HCC patients and 520 healthy controls. The genotypic frequency of the NFKB1 -94 Ins polymorphism in HCC patients was significantly higher than that of the controls (adjusted odds ratio (AOR) = 2.23; 95% confidence interval (CI) 1.32~3.77). No statistical significance was observed for the distribution frequency of the NFKBIA --519 C/T, -826 C/T, or -881 A/G genotype and haplotype polymorphisms between HCC patients and controls. Furthermore, female HCC patients carrying the NFKB1 -94 Ins polymorphism were associated with lower clinical stages and smaller tumor sizes. Conclusions: Our results indicate that the NFKB1 -94 Ins promoter polymorphism increased the risk of HCC, and may be applied as a predictive factor for the clinical stage and tumor size in female HCC patients.

UR - http://www.scopus.com/inward/record.url?scp=84874015984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874015984&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0056130

DO - 10.1371/journal.pone.0056130

M3 - Article

C2 - 23457512

AN - SCOPUS:84874015984

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 2

M1 - e56130

ER -